Compare Vaccine Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Gilead SciencesJohnson & JohnsonModernaNovavaxPfizer
SymbolNASDAQ:GILDNYSE:JNJNASDAQ:MRNANASDAQ:NVAXNYSE:PFE
Price Information
Current Price$65.11$161.25$140.92$179.74$36.60
52 Week RangeBuyBuyHoldBuyHold
MarketRank™
Overall Score2.82.71.61.62.4
Analysis Score4.33.42.23.42.1
Community Score3.32.53.03.12.9
Dividend Score3.34.20.00.03.3
Ownership Score1.71.70.80.81.7
Earnings & Valuation Score1.31.91.90.61.9
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyHold
Consensus Price Target$97.23$180.64$149.65$229.64$38.57
% Upside from Price Target49.33% upside12.03% upside6.19% upside27.76% upside5.39% upside
Trade Information
Market Cap$81.98 billion$424.52 billion$56.44 billion$13.28 billion$204.14 billion
Beta0.510.71.732.010.7
Average Volume8,620,0998,134,38311,728,6414,223,30132,328,539
Sales & Book Value
Annual Revenue$22.45 billion$82.06 billion$60.21 million$18.66 million$51.75 billion
Price / Sales3.655.17937.42711.443.94
Cashflow$7.72 per share$11.76 per shareN/AN/A$4.08 per share
Price / Cash8.4313.71N/AN/A8.97
Book Value$17.90 per share$22.60 per share$3.49 per share($5.75) per share$11.46 per share
Price / Book3.647.1340.38-31.263.19
Profitability
Net Income$5.39 billion$15.12 billion$-514,020,000.00$-132,690,000.00$16.27 billion
EPS$6.14$8.68($1.55)($5.80)$2.95
Trailing P/E Ratio67.1225.35N/AN/A23.61
Forward P/E Ratio9.2918.1413.4910.1811.96
P/E Growth0.673.060.53N/A2.79
Net Margins5.48%21.01%-242.73%-133.10%17.85%
Return on Equity (ROE)37.77%34.64%-28.11%-1,346.17%24.88%
Return on Assets (ROA)12.76%13.40%-20.31%-45.85%9.32%
Dividend
Annual Payout$2.84$4.04N/AN/A$1.56
Dividend Yield4.36%2.51%N/AN/A4.26%
Three-Year Dividend Growth30.77%19.88%N/AN/A-10.94%
Payout Ratio46.25%46.54%N/AN/A52.88%
Years of Consecutive Dividend Growth1 Years59 YearsN/AN/A1 Years
Debt
Debt-to-Equity Ratio1.65%0.51%0.04%3.61%0.76%
Current Ratio3.25%1.48%2.43%2.81%1.40%
Quick Ratio3.15%1.24%2.43%2.81%1.13%
Ownership Information
Institutional Ownership Percentage76.36%67.25%51.21%49.91%67.36%
Insider Ownership Percentage0.13%0.27%29.20%3.30%0.08%
Miscellaneous
Employees13,600134,5001,30079288,300
Shares Outstanding1.26 billion2.63 billion400.53 million73.86 million5.58 billion
Next Earnings Date4/29/2021 (Estimated)4/20/2021 (Confirmed)5/6/2021 (Estimated)5/10/2021 (Estimated)5/4/2021 (Confirmed)
OptionableOptionableOptionableOptionableOptionableOptionable

Latest Vaccine News

SourceHeadline
Pfizer asks US to allow more kids to get vaccine - WAFBPfizer asks US to allow more kids to get vaccine - WAFB
wafb.com - April 11 at 10:15 PM
NET Health announces 1st-dose Pfizer vaccine clinics in Tyler for week of April 12 - KLTVNET Health announces 1st-dose Pfizer vaccine clinics in Tyler for week of April 12 - KLTV
kltv.com - April 11 at 10:15 PM
Local parents will get teens vaccinated if Pfizer gets emergency use approval - nbc25news.comLocal parents will get teens vaccinated if Pfizer gets emergency use approval - nbc25news.com
nbc25news.com - April 11 at 10:15 PM
Covid variant from South Africa was able to ‘break through’ Pfizer vaccine in Israeli study - CNBCCovid variant from South Africa was able to ‘break through’ Pfizer vaccine in Israeli study - CNBC
cnbc.com - April 11 at 10:15 PM
Top China official admits its COVID-19 vaccines have low effectivenessTop China official admits its COVID-19 vaccines have low effectiveness
finance.yahoo.com - April 11 at 10:15 PM
Pfizer asks U.S. to authorize its COVID vaccine for kids 12-15 - NJ.comPfizer asks U.S. to authorize its COVID vaccine for kids 12-15 - NJ.com
nj.com - April 11 at 5:14 PM
How much can Netanyahu squeeze the lemon that is Pfizer CEO? - HaaretzHow much can Netanyahu squeeze the lemon that is Pfizer CEO? - Haaretz
haaretz.com - April 11 at 5:14 PM
Pfizer’s vaccine EUA expansion request is ‘extremely welcomed’: Doctor - Yahoo FinancePfizer’s vaccine EUA expansion request is ‘extremely welcomed’: Doctor - Yahoo Finance
finance.yahoo.com - April 11 at 12:14 PM
What are the side-effects of the Pfizer vaccine? - NHK WORLDWhat are the side-effects of the Pfizer vaccine? - NHK WORLD
www3.nhk.or.jp - April 11 at 12:14 PM
COVID In Colorado: Centura Health Switches From Johnson & Johnson To Pfizer & Moderna Vaccines - CBS DenverCOVID In Colorado: Centura Health Switches From Johnson & Johnson To Pfizer & Moderna Vaccines - CBS Denver
denver.cbslocal.com - April 11 at 12:14 PM
The Pfizer/BioNTech Covid-19 Vaccine Is Less Effective Against The South African And UK Variants Than Against The Original Virus, According To A New “real-World” Study From Israel - ForbesThe Pfizer/BioNTech Covid-19 Vaccine Is Less Effective Against The South African And UK Variants Than Against The Original Virus, According To A New “real-World” Study From Israel - Forbes
forbes.com - April 11 at 12:14 PM
UPDATE 1-South African variant may evade protection from Pfizer vaccine, Israeli study saysUPDATE 1-South African variant may evade protection from Pfizer vaccine, Israeli study says
finance.yahoo.com - April 11 at 12:14 PM
China considering mixing COVID-19 vaccines to boost protection rateChina considering mixing COVID-19 vaccines to boost protection rate
financialpost.com - April 11 at 10:43 AM
Pfizer requests emergency use authorization to administer COVID-19 vaccine to teens - WREX-TVPfizer requests emergency use authorization to administer COVID-19 vaccine to teens - WREX-TV
wrex.com - April 11 at 7:13 AM
Centura transitions three vaccine sites to Moderna and Pfizer only - 9News.com KUSACentura transitions three vaccine sites to Moderna and Pfizer only - 9News.com KUSA
9news.com - April 11 at 7:13 AM
Israeli Study Shows Pfizer Vaccine Less Effective Against South African Variant - http://hamodia.comIsraeli Study Shows Pfizer Vaccine Less Effective Against South African Variant - http://hamodia.com
hamodia.com - April 11 at 7:13 AM
3 Great Dividend Stocks to Buy Right Now3 Great Dividend Stocks to Buy Right Now
finance.yahoo.com - April 11 at 7:13 AM
COVID: Pfizer asks FDA to authorize vaccine for children 12 to 15 years old - The Mercury NewsCOVID: Pfizer asks FDA to authorize vaccine for children 12 to 15 years old - The Mercury News
mercurynews.com - April 10 at 10:37 PM
Pfizer, doctors push for children to get COVID shot - KGW.comPfizer, doctors push for children to get COVID shot - KGW.com
kgw.com - April 10 at 10:37 PM
Pfizer asks FDA to allow its COVID-19 vaccine for younger teens - MyFoxZone.com KIDYPfizer asks FDA to allow its COVID-19 vaccine for younger teens - MyFoxZone.com KIDY
myfoxzone.com - April 10 at 10:37 PM
Pfizer Requests FDA Approval to Use Its COVID Vaccine in Kids Ages 12 to 15 - PEOPLEPfizer Requests FDA Approval to Use Its COVID Vaccine in Kids Ages 12 to 15 - PEOPLE
people.com - April 10 at 5:36 PM
South African Variant Can Break Through Pfizer Vaccine, Israeli Study Says - U.S. News & World ReportSouth African Variant Can 'Break Through' Pfizer Vaccine, Israeli Study Says - U.S. News & World Report
usnews.com - April 10 at 5:36 PM
Pfizer aims to offer COVID vaccine to children in time for 2021 school year, if authorized - 11Alive.com WXIAPfizer aims to offer COVID vaccine to children in time for 2021 school year, if authorized - 11Alive.com WXIA
11alive.com - April 10 at 5:36 PM
South African variant can ‘break through’ Pfizer vaccine, Israeli study saysSouth African variant can ‘break through’ Pfizer vaccine, Israeli study says
financialpost.com - April 10 at 4:21 PM
The Latest: Vaccine shortages hitting poor countries The Latest: Vaccine shortages hitting poor countries
marketbeat.com - April 10 at 2:13 PM
Pfizer said to warn Israel: Pay up or go to the back of vaccine line - The Times of IsraelPfizer said to warn Israel: Pay up or go to the back of vaccine line - The Times of Israel
timesofisrael.com - April 10 at 12:36 PM
The Latest: Pfizer asks US to allow more kids to get vaccineThe Latest: Pfizer asks US to allow more kids to get vaccine
marketbeat.com - April 9 at 5:03 PM
Australia to buy extra 20 million doses of Pfizer vaccineAustralia to buy extra 20 million doses of Pfizer vaccine
marketbeat.com - April 9 at 12:57 AM
Australia halts AstraZeneca vaccine for most people under 50Australia halts AstraZeneca vaccine for most people under 50
marketbeat.com - April 8 at 7:28 AM
Pfizer (NYSE:PFE) Now Covered by Analysts at Royal Bank of CanadaPfizer (NYSE:PFE) Now Covered by Analysts at Royal Bank of Canada
marketbeat.com - April 7 at 8:44 AM
The Latest: Arizona AG says governor cant block mask rulesThe Latest: Arizona AG says governor can't block mask rules
marketbeat.com - April 6 at 9:45 PM
The Latest: Wife of Montana governor also tests positiveThe Latest: Wife of Montana governor also tests positive
marketbeat.com - April 6 at 7:19 PM
The Latest: Tennessee governor opposes vaccine passportsThe Latest: Tennessee governor opposes vaccine passports
marketbeat.com - April 6 at 6:14 PM
The Latest: Chile delays several elections amid virus surgeThe Latest: Chile delays several elections amid virus surge
marketbeat.com - April 6 at 5:04 PM
The Latest: California aims to reopen more widely in JuneThe Latest: California aims to reopen more widely in June
marketbeat.com - April 6 at 3:45 PM
The Latest: Turkeys daily virus cases reach nearly 50,000The Latest: Turkey's daily virus cases reach nearly 50,000
marketbeat.com - April 6 at 3:29 PM
The Latest: WH: No credential to show if vaccinatedThe Latest: WH: No credential to show if vaccinated
marketbeat.com - April 6 at 2:57 PM
The Latest: WH: 28M vaccines doses to states this weekThe Latest: WH: 28M vaccines doses to states this week
marketbeat.com - April 6 at 1:39 PM
The Latest: WH: 28M vaccine doses to states this weekThe Latest: WH: 28M vaccine doses to states this week
marketbeat.com - April 6 at 1:38 PM
The Latest: Study: Moderna vaccine lasts at least 6 monthsThe Latest: Study: Moderna vaccine lasts at least 6 months
marketbeat.com - April 6 at 12:31 PM
Young professionals cut ahead of older Italians for vaccineYoung professionals cut ahead of older Italians for vaccine
marketbeat.com - April 3 at 2:35 AM
Dutch temporarily halt AstraZeneca shots for under-60s Dutch temporarily halt AstraZeneca shots for under-60s
marketbeat.com - April 2 at 11:47 AM
The Latest: France orders school closure, travel banThe Latest: France orders school closure, travel ban
marketbeat.com - March 31 at 3:28 PM
The Latest: Coronavirus pushed US deaths past 3.3M last yearThe Latest: Coronavirus pushed US deaths past 3.3M last year
marketbeat.com - March 31 at 2:16 PM
The Latest: Wisconsin Supreme Court strikes mask mandateThe Latest: Wisconsin Supreme Court strikes mask mandate
marketbeat.com - March 31 at 11:52 AM
The Latest: China pushes virus origin search beyond borderThe Latest: China pushes virus origin search beyond border
marketbeat.com - March 31 at 9:58 AM
The Latest: Pfizer: Vaccine safe in kids as young as 12  The Latest: Pfizer: Vaccine safe in kids as young as 12
marketbeat.com - March 31 at 8:38 AM
Pfizer says COVID-19 vaccine protects kids as young as 12, which could open door for expanded use in children by fallPfizer says COVID-19 vaccine protects kids as young as 12, which could open door for expanded use in children by fall
marketbeat.com - March 31 at 7:08 AM
Pfizer says its COVID-19 vaccine protects younger teensPfizer says its COVID-19 vaccine protects younger teens
marketbeat.com - March 31 at 7:08 AM
The Latest: Italy orders 5-day quarantine on entries from EUThe Latest: Italy orders 5-day quarantine on entries from EU
marketbeat.com - March 30 at 10:22 AM

Latest Vaccine Analyst Ratings

DateCompanyBrokerageAction
4/1/2021Gilead SciencesSanford C. BernsteinUpgrade
3/30/2021Gilead SciencesRedburn PartnersUpgrade
2/11/2021Gilead SciencesSVB LeerinkLower Price Target
2/5/2021Gilead SciencesCredit Suisse GroupBoost Price Target
2/5/2021Gilead SciencesMorgan StanleyBoost Price Target
1/4/2021Gilead SciencesGuggenheimUpgrade
12/22/2020Gilead SciencesCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellLower Price Target
12/22/2020Gilead SciencesSmith Barney CitigroupLower Price Target
12/18/2020Gilead SciencesTruist FinancialLower Price Target
12/17/2020Gilead SciencesOppenheimerLower Price Target
12/16/2020Gilead SciencesBMO Capital MarketsLower Price Target
12/16/2020Gilead SciencesRobert W. BairdBoost Price Target
12/15/2020Gilead SciencesPiper SandlerLower Price Target
12/8/2020Gilead SciencesJPMorgan Chase & Co.Reiterated Rating
10/29/2020Gilead SciencesCantor FitzgeraldReiterated Rating
10/29/2020Gilead SciencesBarclaysLower Price Target
10/29/2020Gilead SciencesWells Fargo & CompanyLower Price Target
1/27/2021Johnson & JohnsonRaymond JamesBoost Price Target
1/27/2021Johnson & JohnsonCowenBoost Price Target
8/19/2020Johnson & JohnsonStifel NicolausDowngrade
7/20/2020Johnson & JohnsonBank of AmericaReiterated Rating
7/20/2020Johnson & JohnsonIndependent ResearchUpgrade
3/8/2021ModernaChardan CapitalBoost Price Target
3/4/2021ModernaBrookline Capital ManagementBoost Price Target
2/18/2021ModernaJefferies Financial GroupBoost Price Target
3/18/2021NovavaxHC WainwrightBoost Price Target
2/1/2021NovavaxB. RileyBoost Price Target
8/5/2020NovavaxLADENBURG THALM/SH SHDowngrade
4/7/2021PfizerRoyal Bank of CanadaInitiated Coverage
4/6/2021PfizerThe Goldman Sachs GroupSet Price Target
3/23/2021PfizerBerenberg BankReiterated Rating
2/3/2021PfizerDZ BankReiterated Rating
2/3/2021PfizerMizuhoLower Price Target
(Data available from 4/11/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.